AZN R&D Expense Growth
AstraZeneca PLC Ordinary Shares · R&D Expense Growth
AZN R&D Expense Growth
Latest reported4.78%period ending
AZN FY R&D Growth (YoY) (0.00% → 4.78%)
Latest values, visible window
High-resolution chart · PNG
AZN r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 4.778% | |
| 24.2158% | |
| 12.016% | |
| 0.2671% | |
| 62.5104% | |
| -1.1223% | |
| 2.1409% | |
| 3.0398% | |
| -2.2581% | |
| -1.7842% | |
| 7.4924% | |
| 15.7229% | |
| -8.0488% | |
| -5.0697% | |
| 3.8548% | |
| 20.6169% | |
| -14.8677% | |
| 0.3293% | |
| 32.2911% | |
| 15.478% | |
| -2.5382% | |
| 15.1062% | |
| -1.8573% | |
| 14.2166% | |
| -7.1723% | |
| 17.0959% | |
| 17.5464% | |
| 94.8157% | |
| 4.7097% | |
| 21.5255% | |
| 4.7514% | |
| 5.4887% | |
| 13.4914% | |
| -3.855% | |
| -0.0704% | |
| 0% |